Or , take the example of prostate cancer screening on a certain demographic . The U . S . Preventive Services Task Force , an independent panel of nongovernment clinicians who provide evidence based practice guidelines , recommends against screening men over age 75 for prostate cancer . Studies have shown that the benefit of prostate cancer screening is uncertain and further tempered by the complications from treatment , which can include impotence and urinary incontinence . However , a December 2011 study from the Archives of Internal Medicine reveals that more than half of men over 75 continue to undergo prostate cancer screenings .
